Ketamine Meets 'Gold Standard' in Major Depression Trial
SAN FRANCISCO — Ketamine is as effective as electroconvulsive therapy (ECT) in improving treatment-resistant major depression in outpatients without psychotic features, according to the ELEKT-D randomized trial. After the 3-week treatment period, 55.4% of patients in the ketamine group and 41.2% of patients in the ECT group responded to treatment, a difference of 14.2% […]